Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Securities in F&O Ban:
Sammaan Capital shares are banned from F&O trading on 04 February 2026.
New SME Listing:
Accretion Nutraveda is set to list on the SME Platform today. The issue opened for bidding 28 January 2026 and it closed 30 January 2025. The price band of the IPO was fixed between Rs 122 to Rs 129 per share. The issue was subscribed 1.77 times.
Msafe Equipment set to debut on the SME platform today. The issue opened for bidding on 28 January 2026 and it closed on 30 January 2025. The price band of the IPO was fixed between Rs 116 to Rs 123 per share. The issue was subscribed 153.98 times.
Kanishk Aluminium India will list on SME platform today. The issue opened for bidding on 28 January 2026 and it closed 30 January 2026. The price band of the IPO was fixed at Rs 73 per share. The minimum order quantity is 1,600 equity shares.
Result Today:
Archean Chemical Industries, Apollo Tyres, Aptus Value Housing Finance India, Aurionpro Solutions, Automotive Axles, Avalon Technologies, Bajaj Finserv, Bajaj Holdings & Investment, Carysil, CCL Products (India), Century Plyboards (India), Cera Sanitaryware, Cummins India, Devyani International, Emami, Emcure Pharmaceuticals, Eureka Forbes, Force Motors, Gallantt Ispat, Greenply Industries, Hexaware Technologies, Inventurus Knowledge Solutions, Jain Irrigation Systems, Jaiprakash Power Ventures, JSW Cement, Jubilant Ingrevia, Kalpataru Projects International, Lloyds Engineering Works, Global Health, Metropolis Healthcare, NHPC, Parag Milk Foods, Apeejay Surrendra Park Hotels, Pokarna, Quality Power Electrical Equipments, Redington, RITES, Rane (Madras), Keystone Realtors, Saatvik Green Energy, Sammaan Capital, Shipping Corporation of India Land and Assets, Tata Power Company, Transport Corporation of India, TeamLease Services, Tube Investments of India, Timken India, Tamilnad Mercantile Bank, Trent, Welspun Enterprises, Westlife Foodworld, Wonderla Holidays and Xpro India will announce their quarterly earnings today.
Stocks to Watch:
Bajaj Finance reported 6.33% decline in consolidated net profit to Rs 3,977.85 crore in Q3 FY26 compared with Rs 4,246.54 crore in Q3 FY25. Total revenue from operations jumped 17.63% YoY to Rs 21,213.89 crore in Q3 FY26.
Mankind Pharma reported a 7.6% year-on-year increase in consolidated net profit to Rs 409 crore, driven by an 11.5% rise in revenue from operations to Rs 3,567 crore in Q3 FY26, compared with Q3 FY25.
Godrej Agrovet posted a 3% year-on-year growth in consolidated net profit to Rs 115 crore, while revenue increased 11% to Rs 2,718 crore in Q3 FY26 over Q3 FY25.
Rubucon Research reported 91.2% jump in consolidated net profit to Rs 72.8 crore on 51.7% increase in revenue from operations to Rs 475.5 crore in Q3 FY26 over Q3 FY25.
Aditya Birla Capital’s consolidated net profit jumped 33.48% to Rs 945.02 crore on 27.4% increase in revenue from operations to Rs 11952.09 crore in Q3 FY36 over Q2 FY25.
Mankind Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 2228.7, up 1.94% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.01% on the day, quoting at 26175.65. The Sensex is at 85535.57, down 0.04%. Mankind Pharma Ltd has gained around 0.27% in last one month.
Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 1.82% in last one month and is currently quoting at 22927.9, down 0.11% on the day. The volume in the stock stood at 3.36 lakh shares today, compared to the daily average of 4.94 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 2231.3, up 2.1% on the day. Mankind Pharma Ltd is down 23.43% in last one year as compared to a 10.32% jump in NIFTY and a 1.52% jump in the Nifty Pharma index.
The PE of the stock is 54.2 based on TTM earnings ending September 25.
Honasa Consumer Ltd, Mankind Pharma Ltd, Pfizer Ltd, Ramkrishna Forgings Ltd are among the other stocks to see a surge in volumes on BSE today, 13 November 2025.
SBI Cards & Payment Services Ltd clocked volume of 20.71 lakh shares by 10:46 IST on BSE, a 97.6 times surge over two-week average daily volume of 21217 shares. The stock gained 0.44% to Rs.874.00. Volumes stood at 8364 shares in the last session.
Honasa Consumer Ltd registered volume of 4.81 lakh shares by 10:46 IST on BSE, a 18.17 fold spurt over two-week average daily volume of 26452 shares. The stock rose 4.38% to Rs.294.30. Volumes stood at 69104 shares in the last session.
Mankind Pharma Ltd witnessed volume of 10.07 lakh shares by 10:46 IST on BSE, a 17.3 times surge over two-week average daily volume of 58232 shares. The stock dropped 0.25% to Rs.2,267.50. Volumes stood at 1.29 lakh shares in the last session.
Pfizer Ltd witnessed volume of 8204 shares by 10:46 IST on BSE, a 14.41 times surge over two-week average daily volume of 569 shares. The stock increased 2.19% to Rs.5,129.75. Volumes stood at 477 shares in the last session.
Ramkrishna Forgings Ltd recorded volume of 2.49 lakh shares by 10:46 IST on BSE, a 12.94 times surge over two-week average daily volume of 19226 shares. The stock gained 6.55% to Rs.574.00. Volumes stood at 24362 shares in the last session.
Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2222.3, down 0.64% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 25609.05. The Sensex is at 83614.62, up 0.09%.Mankind Pharma Ltd has eased around 9.02% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 0.57% in last one month and is currently quoting at 22379.85, down 0.22% on the day. The volume in the stock stood at 2.28 lakh shares today, compared to the daily average of 3.64 lakh shares in last one month.
The benchmark November futures contract for the stock is quoting at Rs 2231.5, down 0.72% on the day. Mankind Pharma Ltd tumbled 15.25% in last one year as compared to a 7.23% rally in NIFTY and a 0.81% spurt in the Nifty Pharma index.
The PE of the stock is 55.39 based on TTM earnings ending September 25.